PRG4 and hepatocellular carcinoma: We have previously demonstrated that PRG4 is secreted by CAFs in HCC, which are one of the major sources of this proteoglycan, and it synergistically enhances the anti-proliferative effects of sorafenib and regorafenib on HCC cells in in vitro two-dimensional cell proliferation models.